Molecular imaging of experimental atherosclerosis using anti-malondialdehyde-modified low-density lipoprotein humanised antibody fragment targeted nanoparticles

Back

ESC Professional Premium Access

Molecular imaging of experimental atherosclerosis using anti-malondialdehyde-modified low-density lipoprotein humanised antibody fragment targeted nanoparticles

Session: Targeting lipids and lipid-related pathways in cardiovascular disease

Topic: Vascular Diseases

Speaker: Doctor A. Hartley (London, GB)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Adam Hartley

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

0 follower

6 more presentations in this session

A novel direct inducible nongenetic murine model of diabetes-aggravated atherosclerosis

Speaker: Doctor S. Gaul (Leipzig, DE)

Access

Abstract

Slides

Plasma eicosanoid profiling in the course of proprotein convertase subtilisin-kexin type 9 inhibition: insights from a metabolomic analysis

Speaker: Doctor L. Schrutka (Vienna, AT)

Access

Abstract

Slides

LXR-beta signalling is a key mediator in the pathogenesis of aortic valve stenosis and its prevention by saringosterol

Speaker: Doctor M. Noethel (Bonn, DE)

Access

Abstract

Slides

Comparison of various low density lipoprotein cholesterol calculators. Is it time for the Friedewald equation to go?

Speaker: Doctor H. Chandran (Chennai, IN)

Access

Abstract

Slides

Human macrophages are immunoprofiled by pericardial fluid small extracellular vesicles modulating lipid metabolism mechanisms.

Speaker: Doctor S. Ben-Aicha (London, GB)

Access

Abstract

Slides

Access the full session

Targeting lipids and lipid-related pathways in cardiovascular disease

Speakers: Doctor A. Hartley, Doctor S. Gaul, Doctor L. Schrutka, Doctor M. Noethel, Doctor H. Chandran...

Access

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources